Angiex

Cambridge, MA · Founded 2015 · Privately Held (backing)

Developer of vascular-targeted biotherapeutics designed for the treatment of solid cancers and other diseases of pathological angiogenesis. Angiex is based in Cambridge, MA and was founded in 2015. Its last reported valuation was $183 million in Aug 2021. It has raised $98.7 million across 2 recorded rounds; the latest was a $22 million early-stage round in Jul 2025.

Last reported valuation
$182.6M
Oct 2026
Priced at
—
Total raised
$98.7M
Last round
Early Stage VC
Jul 2025
What is Angiex worth?
$182.6Mlast reported valuation · Oct 2026

Angiex's last reported valuation, Aug 2021. Nothing priced has surfaced since.

Free account
More of Angiex with a free account
  • ·The complete investor list: 19 names
  • ·Watch Angiex: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Angiex funding history

2 rounds
DateRoundRaisedPost-money
Jul 2025Early Stage VC$22.0M▮
Jul 2017Seed Round$2.9M▮
Unlock post-money valuations

Membership and data by Private Market View

Angiex valuation

Angiex's last reported valuation was $183 million in Aug 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has Angiex raised?

Angiex has raised $98.7 million in total; 2 of its rounds are on record. The largest on record was a $2.9 million seed round in Jul 2017; the most recent was a $22 million early-stage round in Jul 2025.

Angiex has filed 3 Form Ds with the SEC since 2017, most recently in Sep 2025 ($22 million sold to 137 investors).

How Angiex's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Angiex, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Angiex

What is Angiex worth?
Angiex is valued at $182.6M as of Oct 2026. Angiex's last reported valuation, Aug 2021. Nothing priced has surfaced since.
How much has Angiex raised?
Angiex has raised $98.7M in total funding across 2 recorded rounds.
When did Angiex last raise?
Angiex last raised in Jul 2025 (Early Stage VC), raising $22.0M.